Cleveland Clinic's organ preservation research selected as first NADMED award honoree
The Schlegel Lab at Cleveland Clinic has received the inaugural NADMED Award to enhance organ preservation techniques, focusing on NAD/NADH profiling to improve transplant outcomes.
NADMED has named the Schlegel Lab at Cleveland Clinic as the first recipient of the $30,000 NADMED Award for their research to improve how donor organs are preserved and assessed before transplantation.
The project is being led byDr. Keyue Sun and will analyze metabolic organ quality during ischemia and the impact of different machine perfusion strategies using NAD/NADH redox profiling, a technically demanding area that has long lacked reliable measurement tools. This phase is critical in transplantation, where determining whether an organ is viable can directly impact patient outcomes.
The findings are expected to improve how transplant teams assess organ viability and contribute to the development of more effective assessment methods in transplant medicine.
The NADMED Award was created to support research that advances scientific understanding and also has the potential to improve patient outcomes.
